ETI-AB-AUK PLUS assay

FDA Premarket Approval P990042 S028

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

To subcontract manufacturing equipment cleaning processes

DeviceETI-AB-AUK PLUS assay
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantDIASORIN, INC.
Date Received2021-11-23
Decision Date2021-12-21
PMAP990042
SupplementS028
Product CodeLOM 
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address DIASORIN, INC. 1951 Northwestern Ave. stillwater, MN 55082-0285

Supplemental Filings

Supplement NumberDateSupplement Type
P990042Original Filing
S028 2021-11-23 30-day Notice
S027 2020-07-16 30-day Notice
S026 2019-08-28 30-day Notice
S025 2019-06-18 30-day Notice
S024 2018-05-30 30-day Notice
S023 2018-03-30 30-day Notice
S022
S021 2018-02-14 30-day Notice
S020 2017-09-18 30-day Notice
S019 2017-04-25 30-day Notice
S018 2017-03-29 30-day Notice
S017 2016-05-10 30-day Notice
S016 2014-06-05 30-day Notice
S015 2013-12-27 30-day Notice
S014 2013-06-05 30-day Notice
S013 2012-11-09 Special (immediate Track)
S012
S011 2012-02-17 30-day Notice
S010 2011-10-18 30-day Notice
S009 2009-11-13 135 Review Track For 30-day Notice
S008 2008-12-22 Normal 180 Day Track
S007 2004-04-05 30-day Notice
S006 2003-04-07 Normal 180 Day Track No User Fee
S005 2002-10-30 30-day Notice
S004 2002-07-10 Normal 180 Day Track
S003 2002-04-04 Normal 180 Day Track
S002 2002-01-24 Normal 180 Day Track
S001 2001-09-07 Normal 180 Day Track

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.